Zyvox
NDC 0009-5136, linezolid, granule, for suspension, from Pharmacia & Upjohn Company LLC.
- Product NDC
- 0009-5136
- Status
- Listed
- Labeler
- Pharmacia & Upjohn Company LLC
- Dosage form
- GRANULE, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021132
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0009-5136 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LINEZOLID100 mg/5mL
Pharmacologic classes
Oxazolidinone Antibacterial [EPC]; Oxazolidinones [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0009-5136-04 | 00009513604 | 150 mL in 1 BOTTLE (0009-5136-04) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6e70e63b-bfd5-478d-a8ee-8ba22c9efabd
Use it
Look up 0009-5136 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0009-5136 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0009-5136. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.